ir.achillion.com ir.achillion.com

ir.achillion.com

Investors | Achillion Pharmaceuticals

The Investor Relations website contains information about Achillion Pharmaceuticals business for stockholders, potential investors, and financial analysts.

http://ir.achillion.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.ACHILLION.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.6 out of 5 with 8 reviews
5 star
5
4 star
3
3 star
0
2 star
0
1 star
0

Hey there! Start your review of ir.achillion.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.4 seconds

CONTACTS AT IR.ACHILLION.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investors | Achillion Pharmaceuticals | ir.achillion.com Reviews
<META>
DESCRIPTION
The Investor Relations website contains information about Achillion Pharmaceuticals business for stockholders, potential investors, and financial analysts.
<META>
KEYWORDS
1 pipeline
2 overview
3 factor d inhibitors
4 complement mediated diseases
5 dry amd
6 janssen collaboration
7 hcv triple regimen
8 odalasvir
9 sovaprevir
10 compassionate use policy
CONTENT
Page content here
KEYWORDS ON
PAGE
pipeline,overview,factor d inhibitors,complement mediated diseases,dry amd,janssen collaboration,hcv triple regimen,odalasvir,sovaprevir,compassionate use policy,science and technology,complement factor d,resources,about achillion,leadership,investors
SERVER
Microsoft-IIS/8.5
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investors | Achillion Pharmaceuticals | ir.achillion.com Reviews

https://ir.achillion.com

The Investor Relations website contains information about Achillion Pharmaceuticals business for stockholders, potential investors, and financial analysts.

INTERNAL PAGES

ir.achillion.com ir.achillion.com
1

RSS News Feeds | Achillion Pharmaceuticals

http://ir.achillion.com/rss.cfm

Science & Technology. Really Simple Syndication (RSS) is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates. How do I use RSS? To make use of RSS, you'll need an RSS reader, or aggregator. An RSS aggregator can be a stand-alone application, or a plug-in for another program you already use, such as Microsoft Outlook. Some web browsers, such as Firefox. Paste the URL into your reader.

2

Download Library | Achillion Pharmaceuticals

http://ir.achillion.com/downloads.cfm

Science & Technology. 2015 ASH Slide Presentation. 10 results per page. 25 results per page. 50 results per page. 4:00 PM ET on Aug 26, 2016. Delayed at least 20 minutes. This page was last updated on December 6, 2015 at 6:59 pm EST. Achillion Pharmaceuticals, Inc. New Haven, CT 06511. Main 203.624.7000. Fax 203.624.7003. Life in New Haven.

3

Investor FAQs | Achillion Pharmaceuticals

http://ir.achillion.com/faq.cfm

Science & Technology. Where is Achillion Pharmaceuticals located? Achillions corporate offices and research and development operations are located at 300 George Street, New Haven, Connecticut. When was Achillion Pharmaceuticals founded? Achillion Pharmaceuticals, Inc. was incorporated in 1998 and began operations in 2000. When did Achillion go public and at what price? Achillion went public on October 25th, 2006 at an IPO price of $11.50 per share. Where are my stock certificates? Achillions common stock...

4

| Achillion Pharmaceuticals

http://ir.achillion.com/eventdetail.cfm?EventID=160459

Science & Technology. Details on this event are not available. 4:00 PM ET on Aug 18, 2016. Delayed at least 20 minutes. This page was last updated on December 6, 2015 at 6:59 pm EST. Achillion Pharmaceuticals, Inc. New Haven, CT 06511. Main 203.624.7000. Fax 203.624.7003. Life in New Haven.

5

| Achillion Pharmaceuticals

http://ir.achillion.com/eventdetail.cfm?EventID=159909

Science & Technology. Details on this event are not available. 4:00 PM ET on Aug 18, 2016. Delayed at least 20 minutes. This page was last updated on December 6, 2015 at 6:59 pm EST. Achillion Pharmaceuticals, Inc. New Haven, CT 06511. Main 203.624.7000. Fax 203.624.7003. Life in New Haven.

UPGRADE TO PREMIUM TO VIEW 16 MORE

TOTAL PAGES IN THIS WEBSITE

21

SOCIAL ENGAGEMENT



OTHER SITES

ir.acadiarealty.com ir.acadiarealty.com

Acadia Realty Trust - Investor Relations - Investor Relations

Acadia Realty Trust Conference Presentation at NAREIT’s REITWeek Investor Forum. 160;at 11:45 am ET. STRONG FUNDAMENTALS - FOCUSED ON OPPORTUNITY. A company with Strong Fundamentals, A company Focused on Opportunity. Acadia Realty Trust is a publicly traded real estate investment trust (REIT), which specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. American Stock Transfer and Trust Company. 160; 0.19. C Davi...

ir.acc.senshu-u.ac.jp ir.acc.senshu-u.ac.jp

専修大学学術機関リポジトリ(SI-Box)

紀要論文 / Departmental Bulletin Paper. 学位論文 / Thesis or Dissertation. 教材 / Learning Material. 会議発表論文 / Conference Paper. 学位論文 / Thesis or Dissertation 02. 学位論文 / Thesis or Dissertation (2013-). その他 / Others 02. 紀要論文 / Departmental Bulletin Paper 02. 学位論文 / Thesis or Dissertation 03. セルフアーカイブ / Self Archive. 広報資料 / Publicity Material. 図書 / Book 02. 報告書 科研費等 / Research Paper. 学術雑誌論文 / Journal Article. 紀要論文 / Departmental Bulletin Paper. 会議発表論文 / Conference Paper. 学位論文 / Thesis or Dissertation (-2012).

ir.accobrands.com ir.accobrands.com

ACCO Brands - Investor Relations - Investor Relations Home

Receive Materials by Email. Information About Mead Consumer and Office Products Merger. ACCO Brands Corporation (NYSE: ACCO) is one of the world's largest suppliers of select categories of branded school, office and consumer products and print finishing solutions, with revenues of $1.7 billion. We market products in over 100 countries across the globe through our own sales force and distribution networks. Our industry-leading brands and products include AT-A-GLANCE. 160; 0.32. Minimum 20 minute delay.

ir.accretivehealth.com ir.accretivehealth.com

Accretive Health, Inc. | Investor Relations | Investor Relations

Q2 2015 Accretive Health Inc Earnings Conference Call. 160;at 4:30 pm ET. Accretive Health is a leading provider of services and technology to healthcare providers. Our mission is to help our healthcare clients strengthen their financial stability and deliver better care at a more affordable cost to the communities they serve, increasing healthcare access for all. Our distinctive operating model that includes people, process, and sophisticated integrated technology helps our customers realize sus...CHICA...

ir.acelrx.com ir.acelrx.com

AcelRx Pharmaceuticals, Inc : Investors

Q2 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call. 160;at 4:30 pm ET. Q2 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call. Monday, August 3, 2015 . 4:30 pm ET  . Click here for webcast. Click here to add this event to your calendar. ACRX Corporate Presentation - 5/7/15. 160; 0.13. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results. Replication or redistribution of E...

ir.achillion.com ir.achillion.com

Investors | Achillion Pharmaceuticals

Presentations, Fact Sheet,. Life in New Haven. Rooted in the myth of Achilles, the name of Achillion refers to the brave warrior committed to a cause as well as the company’s mission to combat diseases by identifying and exploiting their unique vulnerabilities. Inspiring Science. Innovative Medicine. Mar 8, 2018. Achillion to Present at the Barclays Global Healthcare Conference. Feb 28, 2018. View all press releases ». Mar 15, 2018 at 11:15 AM ET. Barclays Global Healthcare Conference 2018.

ir.acorda.com ir.acorda.com

Acorda Therapeutics Inc - Investors

Investors span LayoutHomePageLayout Languageen-CA". Policy on Access to. Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Policy on Access to. March 26, 2018. Acorda Files Marketing Authorization Application for INBRIJA (levodopa inhalation powder). March 14, 2018. Acorda Rallies Parkinson’s Community in First-of-Its-Kind Initiative to Foster Better Conversations About Parkinson’s Symptoms.

ir.acsf.com ir.acsf.com

Investor Relations Home - Investor Relations - American Capital Senior Floating

Skip to main content. Dividend Reinvestment and Stock Purchase. Receive American Capital Senior Floating. 10-Q Q2 2015 (quarter ending June 30, 2015). 10-Q Q1 2015 (quarter ending March 31, 2015). American Capital Senior Floating, Ltd. Announces Monthly Cash Dividends of $0.097 per Share for August, September and October of 2015. American Capital Senior Floating Reports Net Investment Income of $0.32 per Share. American Capital Senior Floating, Ltd. Will Report Second Quarter 2015 Results on August 3.

ir.actiniumpharma.com ir.actiniumpharma.com

Investor Relations :: Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference. Jan 10, 2017. Ended Sep 30, 2016. Actinium Pharmaceuticals, Inc. Actinium Pharmaceuticals, Inc. New York, NY 10016. 2469 E. Fort Union Blvd. Salt Lake City, UT 84121. Receive the latest news, events and updates! 2017 Actinium Pharmaceuticals, Inc.

ir.activepower.com ir.activepower.com

Investor Overview - Active Power Investors Relations

150 kVA â 1200 kVA). 750 kVA â 3 MVA). Our products are built on our elegant, field proven flywheel technology that delivers an unmatched combination of power density, reliability, and total cost of ownership. This combination enables our customers to achieve their availability, reliability, and budget goals. Q2 2015 Earnings Release. Q2 2015 Active Power, Inc. Earnings Conference Call. Q2 2015 â 10-Q. 160; 0.08. Data as of 08/07/15Â 4:00 pm ET. Minimum 20 minute delay. Active Power to Present at 43rd An...

ir.activisionblizzard.com ir.activisionblizzard.com

Activision Blizzard, Inc. | Investor Relations

Activision Blizzard, Inc. is the largest and most profitable western interactive entertainment publishing company. It develops and publishes some of the most successful and beloved entertainment franchises in any medium, including. Call of Duty,. Call of Duty Online,. Aug 6, 2015. Hellfire Rains on Azeroth in World of Warcraft: Legion™. Aug 5, 2015. Activision Brings Strongest Ever Line-up to Gamescom 2015. Aug 4, 2015 at 1:30 PM PT. Activision Blizzard Second Quarter Calendar 2015 Results Conference Call.